Meiling Zuo

616 total citations
16 papers, 483 citations indexed

About

Meiling Zuo is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Meiling Zuo has authored 16 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Neurology. Recurrent topics in Meiling Zuo's work include MicroRNA in disease regulation (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Mitochondrial Function and Pathology (3 papers). Meiling Zuo is often cited by papers focused on MicroRNA in disease regulation (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Mitochondrial Function and Pathology (3 papers). Meiling Zuo collaborates with scholars based in China, United States and Saudi Arabia. Meiling Zuo's co-authors include Zhong‐Bao Yang, Aiping Wang, Guo‐Huang Hu, He He, Zheng Lou, Chaojun Yan, Zhiyin Song, Li Chen, Zhida Wu and Mao Li and has published in prestigious journals such as Journal of the American Chemical Society, Hepatology and EMBO Reports.

In The Last Decade

Meiling Zuo

16 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiling Zuo China 12 284 151 78 74 63 16 483
Xiaoyu Lu China 16 356 1.3× 198 1.3× 42 0.5× 87 1.2× 48 0.8× 44 595
Hongjun Du China 15 426 1.5× 113 0.7× 54 0.7× 67 0.9× 44 0.7× 36 758
Lingling Yao China 8 312 1.1× 131 0.9× 38 0.5× 36 0.5× 54 0.9× 20 530
Jingni Wu China 13 288 1.0× 130 0.9× 85 1.1× 135 1.8× 22 0.3× 26 527
Xue‐Jiao Xie China 11 307 1.1× 207 1.4× 48 0.6× 49 0.7× 46 0.7× 22 480
Minghua Li China 13 285 1.0× 157 1.0× 44 0.6× 49 0.7× 62 1.0× 22 483
Meng Mao China 10 220 0.8× 80 0.5× 133 1.7× 90 1.2× 73 1.2× 41 429
Chin-San Liu Taiwan 12 366 1.3× 73 0.5× 42 0.5× 38 0.5× 72 1.1× 15 581

Countries citing papers authored by Meiling Zuo

Since Specialization
Citations

This map shows the geographic impact of Meiling Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Zuo more than expected).

Fields of papers citing papers by Meiling Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Zuo. The network helps show where Meiling Zuo may publish in the future.

Co-authorship network of co-authors of Meiling Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Zuo. A scholar is included among the top collaborators of Meiling Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Zuo. Meiling Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Wong, Nai-Kei, You Xu, Yang Guo, et al.. (2023). Visualizing Cardiolipin In Situ with HKCL-1M, a Highly Selective and Sensitive Fluorescent Probe. Journal of the American Chemical Society. 145(20). 11311–11322. 14 indexed citations
3.
Li, Rong, et al.. (2022). Association of lncRNA PVT1 Gene Polymorphisms with the Risk of Essential Hypertension in Chinese Population. BioMed Research International. 2022(1). 9976909–9976909. 5 indexed citations
4.
Li, Mao, et al.. (2022). The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application. Mediators of Inflammation. 2022. 1–10. 16 indexed citations
5.
Chen, Li, Jun Dong, Siyou Wang, et al.. (2022). Loss of Sam50 in hepatocytes induces cardiolipin‐dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury. Hepatology. 76(5). 1389–1408. 84 indexed citations
6.
Deng, Xu, et al.. (2021). MicroRNA-455-5p Contributes to Cholangiocarcinoma Growth and Mediates Galangin's Anti-Tumor Effects. Journal of Cancer. 12(15). 4710–4721. 10 indexed citations
7.
8.
Wu, Zhida, Meiling Zuo, Ling Zeng, et al.. (2020). OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development. EMBO Reports. 22(1). e50827–e50827. 94 indexed citations
9.
Zou, Yang, Rong Li, Meiling Zuo, et al.. (2020). Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA‐21 Expression. BioMed Research International. 2020(1). 5846938–5846938. 20 indexed citations
10.
Zuo, Meiling, et al.. (2020). miR-652 protects rats from cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2. Biomedicine & Pharmacotherapy. 124. 109860–109860. 42 indexed citations
11.
Li, Mao, et al.. (2020). Low expression of miR‑532‑3p contributes to cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2. Molecular Medicine Reports. 22(3). 2415–2423. 23 indexed citations
12.
Zuo, Meiling, et al.. (2019). Oxymatrine ameliorates insulin resistance in rats with type 2 diabetes by regulating the expression of KSRP, PETN, and AKT in the liver. Journal of Cellular Biochemistry. 120(9). 16185–16194. 27 indexed citations
13.
Lou, Zheng, et al.. (2018). Upregulation of NOX2 and NOX4 Mediated by TGF-β Signaling Pathway Exacerbates Cerebral Ischemia/Reperfusion Oxidative Stress Injury. Cellular Physiology and Biochemistry. 46(5). 2103–2113. 75 indexed citations
14.
Lou, Zheng, et al.. (2018). Role of ALK5/SMAD2/3 signaling in the regulation of NOX expression in cerebral ischemia/reperfusion injury. Experimental and Therapeutic Medicine. 16(3). 1671–1678. 18 indexed citations
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyu Lu Breakdown of academic impact, for papers by Hongjun Du Breakdown of academic impact, for papers by Lingling Yao Breakdown of academic impact, for papers by Jingni Wu Breakdown of academic impact, for papers by Xue‐Jiao Xie Breakdown of academic impact, for papers by Minghua Li Breakdown of academic impact, for papers by Meng Mao Breakdown of academic impact, for papers by Chin-San Liu
Rankless by CCL
2026